Cargando…

Maximum human objectively measured pharmacologically stimulated accommodative amplitude

PURPOSE: To measure the maximum, objectively measured, accommodative amplitude, produced by pharmacologic stimulation. METHODS: Thirty-seven healthy subjects were enrolled, with a mean age of 20.2±1.1 years, corrected visual acuity of 20/20, and mean spherical equivalent refraction (SER) =-0.83±1.60...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzybowski, Andrzej, Schachar, Ronald A, Gaca-Wysocka, Magdalena, Schachar, Ira H, Pierscionek, Barbara K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784748/
https://www.ncbi.nlm.nih.gov/pubmed/29403261
http://dx.doi.org/10.2147/OPTH.S154432
_version_ 1783295512238096384
author Grzybowski, Andrzej
Schachar, Ronald A
Gaca-Wysocka, Magdalena
Schachar, Ira H
Pierscionek, Barbara K
author_facet Grzybowski, Andrzej
Schachar, Ronald A
Gaca-Wysocka, Magdalena
Schachar, Ira H
Pierscionek, Barbara K
author_sort Grzybowski, Andrzej
collection PubMed
description PURPOSE: To measure the maximum, objectively measured, accommodative amplitude, produced by pharmacologic stimulation. METHODS: Thirty-seven healthy subjects were enrolled, with a mean age of 20.2±1.1 years, corrected visual acuity of 20/20, and mean spherical equivalent refraction (SER) =-0.83±1.60 diopters. For each subject, the right pupil was dilated with phenylephrine 10%. After 30 minutes, the pupil was measured, the left eye was patched, and the right eye was autorefracted. Pilocarpine 4% was then instilled in the right eye, followed by phenylephrine. At 45 minutes after the pilocarpine, autorefraction and pupil size were again measured. RESULTS: Mean pupil size pre- and postpilocarpine was 8.0±0.8 mm and 4.4±1.9 mm, respectively. Pre- and postpilocarpine, the mean SER was -0.83±1.60 and -10.55±4.26 diopters, respectively. The mean pilocarpine-induced accommodative amplitude was 9.73±3.64 diopters. Five subjects had accommodative amplitudes ≥14.00 diopters. Accommodative amplitude was not significantly related to baseline SER (p-value =0.24), pre- or postpilocarpine pupil size (p-values =0.13 and 0.74), or change in pupil size (p-value =0.37). Iris color did not statistically significantly affect accommodative amplitude (p-value =0.83). CONCLUSION: Following topically applied pilocarpine, the induced objectively measured accommodation in the young eye is greater than or equal to the reported subjectively measured voluntary maximum accommodative amplitude.
format Online
Article
Text
id pubmed-5784748
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57847482018-02-05 Maximum human objectively measured pharmacologically stimulated accommodative amplitude Grzybowski, Andrzej Schachar, Ronald A Gaca-Wysocka, Magdalena Schachar, Ira H Pierscionek, Barbara K Clin Ophthalmol Original Research PURPOSE: To measure the maximum, objectively measured, accommodative amplitude, produced by pharmacologic stimulation. METHODS: Thirty-seven healthy subjects were enrolled, with a mean age of 20.2±1.1 years, corrected visual acuity of 20/20, and mean spherical equivalent refraction (SER) =-0.83±1.60 diopters. For each subject, the right pupil was dilated with phenylephrine 10%. After 30 minutes, the pupil was measured, the left eye was patched, and the right eye was autorefracted. Pilocarpine 4% was then instilled in the right eye, followed by phenylephrine. At 45 minutes after the pilocarpine, autorefraction and pupil size were again measured. RESULTS: Mean pupil size pre- and postpilocarpine was 8.0±0.8 mm and 4.4±1.9 mm, respectively. Pre- and postpilocarpine, the mean SER was -0.83±1.60 and -10.55±4.26 diopters, respectively. The mean pilocarpine-induced accommodative amplitude was 9.73±3.64 diopters. Five subjects had accommodative amplitudes ≥14.00 diopters. Accommodative amplitude was not significantly related to baseline SER (p-value =0.24), pre- or postpilocarpine pupil size (p-values =0.13 and 0.74), or change in pupil size (p-value =0.37). Iris color did not statistically significantly affect accommodative amplitude (p-value =0.83). CONCLUSION: Following topically applied pilocarpine, the induced objectively measured accommodation in the young eye is greater than or equal to the reported subjectively measured voluntary maximum accommodative amplitude. Dove Medical Press 2018-01-22 /pmc/articles/PMC5784748/ /pubmed/29403261 http://dx.doi.org/10.2147/OPTH.S154432 Text en © 2018 Grzybowski et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Grzybowski, Andrzej
Schachar, Ronald A
Gaca-Wysocka, Magdalena
Schachar, Ira H
Pierscionek, Barbara K
Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title_full Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title_fullStr Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title_full_unstemmed Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title_short Maximum human objectively measured pharmacologically stimulated accommodative amplitude
title_sort maximum human objectively measured pharmacologically stimulated accommodative amplitude
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784748/
https://www.ncbi.nlm.nih.gov/pubmed/29403261
http://dx.doi.org/10.2147/OPTH.S154432
work_keys_str_mv AT grzybowskiandrzej maximumhumanobjectivelymeasuredpharmacologicallystimulatedaccommodativeamplitude
AT schacharronalda maximumhumanobjectivelymeasuredpharmacologicallystimulatedaccommodativeamplitude
AT gacawysockamagdalena maximumhumanobjectivelymeasuredpharmacologicallystimulatedaccommodativeamplitude
AT schacharirah maximumhumanobjectivelymeasuredpharmacologicallystimulatedaccommodativeamplitude
AT pierscionekbarbarak maximumhumanobjectivelymeasuredpharmacologicallystimulatedaccommodativeamplitude